Nursing Pharmacology Chapter 28:  Physiology and Pharmacology: Adrenocorticosteroids / Adrenocortical Antagonists

Section Table of Contents

Return to Nursing Pharmacology Table of Contents

Previous Page

Page Forward
 

Synthetic Adrenocorticosteroids

Activity

Drug

Anti-inflammatory

Salt-retaining

Dosage Forms

 

Short/medium-acting glucocorticoid

Hydrocortisone (cortisol)

1

1

oral, injectable, topical

Cortisone (Cortone)

0.8

0.8

oral, injectable, topical

Prednisone (Deltasone)

4

0.3

oral

Prednisolone (Prelone)

5

0.3

oral, injectable, topical

Methylprednisolone (Solu-Medrol)

5

0

oral, injectable, topical

 

Intermediate-acting glucocorticoid

Triamcinolone (Aristocort)

5

0

oral, injectable, topical

Fluprednisolone

15

0

oral

 

Long-acting glucocorticoid

Betamethasone (Celestone)

25-40

0

oral, injectable, topical

Dexamethasone (Decadron)

30

0

oral, injectable, topical

 

Activity

Drug

Anti-inflammatory

Salt-retaining

Dosage Forms

Mineralocorticoids

Fludrocortisone (Florinef)

10

250

oral, injectable, topical

Desoxycorticosterone acetate

0

20

injectable, pellets

Adapted from Table 39-1: Goldfien, A.,Adrenocorticosteroids and Adrenocortical Antagonists, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, p. 640.

 

Section Table of Contents

Return to Nursing Pharmacology Table of Contents

Previous Page

Page Forward
  1. Goldfien, A.,Adrenocorticosteroids and Adrenocortical Antagonists, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 635-650.

  2. Williams, G. H and Dluhy, R. G. , Diseases of the Adrenal Cortex, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 2035-2056